|
Gene therapy could cut new Alzheimer’s cases by a fifth (Belfast Telegraph)
Gene scientists have taken a “leap forward” in Alzheimer's research with the potential to cut rates of the disease by a fifth, it has been revealed. Related Stories Women face delay in getting ovarian disease diagnosed Therapy for breast cancer may trigger even worse tumours Women encouraged to take extra folic acid Gene that could make you immune to obesity Big thighs cut heart disease risk
(Sep 7, 2009)
Chemotherapy Resistance: Checkpoint Protein Provides Armor Against Cancer Drugs (Science Daily)
Cell cycle checkpoints act like molecular tripwires for damaged cells, forcing them to pause and take stock. Leave the tripwire in place for too long, though, and cancer cells will press on regardless, making them resistant to the lethal effects of certain types of chemotherapy, according to researchers.
(Sep 7, 2009)
Key Protein Controlling Brain Formation Identified (Science Daily)
Researchers have identified a protein which plays a key role in the development of neurons, which could enhance our understanding of how the brain works, and how diseases such as Alzheimer's occur.
(Sep 7, 2009)
Diabetes Advance: Researchers Find Gene That Causes Resistance To Insulin (Science Daily)
A breakthrough by an international team of researchers in Canada, France, the UK and Denmark has uncovered a new gene that could lead to better treatment of type 2 diabetes, as well as a better understanding of how this widespread disease develops.
(Sep 7, 2009)
New Alzheimer’s Gene Discovery Sparks Hope for Treatments (Bloomberg)
Sept. 7 (Bloomberg) -- The first new genes tied to Alzheimer’s disease in a decade have been identified by European scientists, adding insight into the biology of the most common cause of dementia and potentially leading to treatments.
(Sep 7, 2009)
Linda Avey Leaves 23andMe to Launch Alzheimer's Foundation (Bio-IT World)
BoomTown | Linda Avey, co-founder of 23andMe with Anne Wojcicki, has left the consumer genomics company to set up a new foundation dedicated to research on Alzheimer's disease, which claimed the life of her father-in-law last year.
(Sep 7, 2009)
In Print (GenomeWeb News)
Title: R/Bioconductor software for Illumina's Infinium whole-genome genotyping BeadChips.
(Sep 7, 2009)
Protein Associated With Alzheimer's Identified By U Of T Researchers (Medical News Today)
Researchers at the University of Toronto have identified a protein which plays a key role in the development of neurons, which could enhance our understanding of how the brain works, and how diseases such as Alzheimer's occur. U of T graduate student John Calarco, working in the labs of Prof. Ben Blencowe (Donnelly Centre for Cellular and Biomolecular Research, University of Toronto) and Prof.
(Sep 7, 2009)
Researchers Restore Missing Protein In Rare Genetic Brain Disorder (Medical News Today)
UCSF researchers have successfully used protease inhibitors to restore to normal levels a key protein involved in early brain development. Reduced levels of that protein have been shown to cause the rare brain disorder lissencephaly, which is characterized by brain malformations, seizures, severe mental retardation and very early death in human infants.
(Sep 7, 2009)
Missing Protein In Rare Genetic Brain Disorder Restored (redOrbit)
UCSF researchers have successfully used protease inhibitors to restore to normal levels a key protein involved in early brain development.
(Sep 7, 2009)
Researchers Find Gene That Causes Insulin Resistance (redOrbit)
Discovery is first gene known to affect how insulin works, not how it is producedA breakthrough by an international team of researchers in Canada, France, the UK and Denmark has uncovered a new gene that could lead to better treatment of type 2 diabetes, as well as a better understanding of how this widespread disease develops.Unlike most of the genes that have been shown to cause diabetes, the ...
(Sep 7, 2009)
Updates from Stem Cell Central (GenomeWeb News)
Wired has a couple of articles on stem cell news. One reports that the California Institute for Regenerative Medicine, launched as a funding source for scientists working with embryonic stem cells, will now award as much as $13 million for research into "techniques that do not destroy human embryos," according to the story.
(Sep 7, 2009)
Scientists find three new gene links to Alzheimer's (Reuters via Yahoo! News)
Scientists have found three new major genetic links to Alzheimer's, affecting up to 20 percent of people with the brain-wasting disease, and said on Sunday it was the most significant such discovery in 15 years.
(Sep 7, 2009)
UK scientists use microbes to clean toxins from oil (TVNZ)
British scientists have used microbes to break down toxins in crude oil
(Sep 7, 2009)
Microbes could clean Great Lakes: scientists (Ottawa Citizen)
British scientists have used microbes to break down toxins in crude oil and say the technique could be used in refining as well as to clear up pollutants left in vast Canadian lakes when oil is extracted from tar sands.
(Sep 7, 2009)
New Alzheimer’s Gene Discovery Sparks Hope for Treatments (Bloomberg)
Sept. 7 (Bloomberg) -- The first new genes tied to Alzheimer’s disease in a decade have been identified by European scientists, adding insight into the biology of the most common cause of dementia and potentially leading to treatments.
(Sep 7, 2009)
Genomes Reveal Bacterial Lifestyles (redOrbit)
Provides tool for tracking environmental changeIn line with the U.S. Department of Energy (DOE) interest in characterizing the biotic factors involved in global carbon cycling, the DOE Joint Genome Institute (JGI) characterizes a diverse array of plants, microorganisms, and the communities in which they reside to inform options for reducing and stabilizing atmospheric greenhouse gases.Through a ...
(Sep 7, 2009)
New Genomic Model Defines Microbes By Diet; Provides Tool For Tracking Environmental Change (Science Daily)
Through a novel genomic approach, an international team of scientists demonstrates how the microbial diversity of the oceans can be analyzed without necessarily cultivating samples in the laboratory.
(Sep 7, 2009)
Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier (News-Medical-Net)
Earlier this year, researchers at the University of Washington reported that they had developed a toxin-nanoparticle combination that inhibits brain cancer invasion when added to tumor cells growing in culture.
(Sep 7, 2009)
Tag:genomics (Business Weekly)
The East of England business news source, covering Cambridge-shire, Essex, Hertfordshire, Norfolk, Northants, Milton Keynes and Suffolk. About us
(Sep 7, 2009)
NASA Spaceline Current Awareness 31 July 2009 (SpaceRef)
NASA Spaceline Current Awareness 31 July 2009
(Sep 8, 2009)
OncQuest introduces NPM 1 Exon 12 mutation for prognosis of AML with Normal Karyotype (PharmaBiz)
OncQuest Laboratories Ltd., the pioneer in oncology clinical testing in the country has launched NPM 1 Exon 12 Mutation Analysis to ascertain the outcome of disease in patients suffering from Acute Myeloid Leukaemia (AML). The test is recommended for patients who have normal chromosomal arrangement which is tested using conventional karyotype or cytogenetic analysis.
(Sep 8, 2009)
Nobel winner to lead ASU health effort (The Arizona Republic)
Lee Hartwell lead a new Biodesign Institute research center that will include medical research. The group has held talks with officials Singapore, Japan and other nations.
(Sep 8, 2009)
Prevent periodontitis to reduce the risk of head and neck cancer (EurekAlert!)
( American Association for Cancer Research ) Chronic periodontitis, a form of gum disease, is an independent risk factor for head and neck squamous cell carcinoma. This suggests the need for increased efforts to prevent and treat periodontitis as a possible means to reduce the risk of this form of cancer.
(Sep 8, 2009)
Prevent Periodontitis to Reduce the Risk of Head and Neck Cancer (Newswise)
1) Chronic periodontitis increases risk; 2) Smoking may be a modifier.
(Sep 8, 2009)
Chronic periodontitis linked to head and neck cancer (News-Medical-Net)
Chronic periodontitis, a form of gum disease, is an independent risk factor for head and neck squamous cell carcinoma. This suggests the need for increased efforts to prevent and treat periodontitis as a possible means to reduce the risk of this form of cancer.
(Sep 8, 2009)
Johnson & Johnson Honors 2009 Recipient of The Dr. Paul Janssen Award for Biomedical Research (PR Newswire via Yahoo! Finance)
Johnson & Johnson today honored the career achievements of Axel Ullrich, Ph.D., with the 2009 Dr. Paul Janssen Award for Biomedical Research. Dr. Ullrich received this award for his scientific discoveries that led to innovative new drugs including Herceptin *, a personalized medicine therapy, which was the first to target a specific type of breast cancer.
(Sep 8, 2009)
Prevent Periodontitis To Reduce The Risk Of Head And Neck Cancer (Science Daily)
Chronic periodontitis, a form of gum disease, is an independent risk factor for head and neck squamous cell carcinoma. This suggests the need for increased efforts to prevent and treat periodontitis as a possible means to reduce the risk of this form of cancer.
(Sep 8, 2009)
Comprehensive analysis of the Japanese blood banking market (News-Medical-Net)
Research and Markets has announced the addition of the "The Japanese Blood Banking Market through 2013" report to their offering.
(Sep 8, 2009)
Johnson & Johnson Honors 2009 Recipient of The Dr. Paul Janssen Award for Biomedical Research (redOrbit)
BEERSE, Belgium, Sept. 8 /PRNewswire/ -- Johnson & Johnson today honored the career achievements of Axel Ullrich, Ph.D., with the 2009 Dr. Paul Janssen Award for Biomedical Research. Dr.
(Sep 8, 2009)
University Of Southern California Study Explains Major Cause Of Drug-Resistance In Chronic Myeloid Leukemia (Medical News Today)
Researchers at the Keck School of Medicine of the University of Southern California (USC) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) have discovered high concentrations of a specific mutator protein in cells that develop resistance to drug treatment in chronic myeloid leukemia (CML).
(Sep 8, 2009)
Biomatrica Makes Several Key Appointments as Part of Continued Growth Plan (PR Newswire via Yahoo! Finance)
Biomatrica, Inc., the leader in room temperature sample storage and stabilization, today announced several key appointments that will expand the breadth of leadership and commercial experience of its management team.
(Sep 8, 2009)
GeneGo Licenses MetaCore to Proteostasis Therapeutics (PR Newswire via Yahoo! Finance)
GeneGo, Inc., the leading systems biology tools company, announced today that Proteostasis Therapeutics has licensed its data mining and analysis platform, MetaCore.
(Sep 8, 2009)
AXA Diagnostics Named Exclusive Distributor for Rosetta Genomics' microRNA-based Assays in Italy (Business Wire via Yahoo! Finance)
REHOVOT, Israel & PHILADELPHIA & ROME----Rosetta Genomics, Ltd. , a leading developer of microRNA-based molecular diagnostics, and AXA Diagnostics, a privately owned company that markets specialized diagnostic tests, announced today the signing of an exclusive distribution agreement in Italy for Rosetta Genomics’ three currently available diagnostic tests.
(Sep 8, 2009)
nanoviricides drug pipeline to be discussed at NanoBusiness2009 (News-Medical-Net)
NanoViricides, Inc. (the "Company"), announced today that Anil Diwan, PhD, President of the Company has been asked to present a talk at NanoBusiness2009 - the 8th annual NanoBusiness Conference.
(Sep 8, 2009)
MDRNA Adds June D. Ameen to Management Team as Vice President, Corporate Development (Marketwire via Yahoo! Finance)
BOTHELL, WA--(Marketwire - 09/08/09) - MDRNA, Inc. (NASDAQ: MRNA - News ) announced today that June D. Ameen, RN, MBA, will join the Company as Vice President, Corporate Development reporting to the President & CEO. Ms. Ameen will lead the alliance management, business development, technology evaluation and strategic partnering efforts for the Company. "We are extremely pleased to have June join ...
(Sep 8, 2009)
RiNA GmbH Acquires Roche RTS Protein Expression Portfolio (Business Wire via Yahoo! Finance)
PENZBERG, Germany----Roche and RiNA GmbH of Berlin have agreed to transfer the complete Roche Applied Science RTS Protein Expression portfolio to RiNA GmbH, effective September 15, 2009.
(Sep 8, 2009)
BEST bags orders valued $3.7 million for its state-of-the-art synchrotron instrumentation (News-Medical-Net)
Bruker Energy & Supercon Technologies, Inc. (BEST) today announced that its subsidiary Bruker ASC GmbH in Bergisch Gladbach, Germany, has been awarded several significant contracts for state-of-the-art synchrotron instrumentation from leading research institutions worldwide.
(Sep 8, 2009)
MDRNA Adds June D. Ameen to Management Team as Vice President, Corporate Development (Marketwire)
BOTHELL, WA--(Marketwire - September 8, 2009) - MDRNA, Inc. ( NASDAQ : MRNA ) announced today that June D. Ameen, RN, MBA, will join the Company as Vice President, Corporate Development reporting to the President & CEO. Ms. Ameen will lead the alliance management, business development, technology evaluation and strategic partnering efforts for the Company. "We are extremely pleased to have June ...
(Sep 8, 2009)
Cell Biosciences Signs Agreement to Acquire Alpha Innotech (Business Wire via Yahoo! Finance)
SANTA CLARA, Calif.----Cell Biosciences, Inc. and Alpha Innotech Corp. today announced that they have entered into a definitive agreement providing for the acquisition of Alpha Innotech by Cell Biosciences for $1.50 per share, or approximately $17.9 million in cash.
(Sep 8, 2009)
Rosetta Genomics and AXA Diagnostics sign an exclusive distribution agreement (News-Medical-Net)
Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, and AXA Diagnostics, a privately owned company that markets specialized diagnostic tests, announced today the signing of an exclusive distribution agreement in Italy for Rosetta Genomics’ three currently available diagnostic tests.
(Sep 8, 2009)
Preventing Periodontitis Could Reduce Risk Of Head, Neck Cancer (redOrbit)
Chronic periodontitis, a form of gum disease, is an independent risk factor for head and neck squamous cell carcinoma.
(Sep 8, 2009)
Roche RTS Protein Expression portfolio transferred to RiNA GmbH (News-Medical-Net)
Roche and RiNA GmbH of Berlin have agreed to transfer the complete Roche Applied Science RTS Protein Expression portfolio to RiNA GmbH, effective September 15, 2009.
(Sep 8, 2009)
Prevent Periodontitis To Reduce The Risk Of Head And Neck Cancer (Medical News Today)
Chronic periodontitis, a form of gum disease, is an independent risk factor for head and neck squamous cell carcinoma. This suggests the need for increased efforts to prevent and treat periodontitis as a possible means to reduce the risk of this form of cancer. "Prevent periodontitis; if you have it already, get treatment and maintain good oral hygiene," said Mine Tezal, D.D.S., Ph.D.
(Sep 8, 2009)
Georgia Cancer Coalition lauds 4 at UGA (Atlanta Business Chronicle)
Four cancer researchers at The University of Georgia are among 18 named Distinguished Cancer Clinicians and Scientists by the Georgia Cancer Coalition for 2009-2010.
(Sep 8, 2009)
For Regular People, a List of Places to Avoid (GenomeWeb News)
Wired released its list of "top tech towns" (read: geek gathering zones) in the US. The magazine says it used "highly scientific methodology as well as algorithms snuck out of NASA and Google" to evaluate 30 cities on a number of factors, including proximity to highly ranked engineering schools, tech jobs per capita, free Wi-Fi availability, and more.
(Sep 8, 2009)
RiNA Acquires Roche's RTS Protein Expression Portfolio (GenomeWeb News)
NEW YORK (GenomeWeb News) – Berlin-based RiNA has acquired Roche Applied Science's RTS Protein Expression portfolio of cell-free expression kits for an undisclosed sum, Roche said today.
(Sep 8, 2009)
Rosetta Genomics Taps Italian Distributor (GenomeWeb News)
NEW YORK (GenomeWeb News) – AXA Diagnostics will distribute Rosetta Genomics' microRNA-based miRview line of molecular diagnostic cancer tests in Italy, Rosetta said today.
(Sep 8, 2009)
First DNA Barcodes Of Commonly Traded Bushmeat: New Tool For Tracking Global Trade In Wildlife (Science Daily)
Researchers have published the DNA barcodes of commonly traded bushmeat from Central Africa and South America. DNA barcodes -- short genetic sequences that can be readily obtained and pinpoint the species of origin of any product -- offer wildlife enforcement a new tool in the international trade of wildlife.
(Sep 8, 2009)
Q&A: Calling for a Standard Format so Protein Affinity Reagent Databases Can 'Talk' to Each Other (GenomeWeb News)
In recent years, a number of initiatives has been started to tackle the poor quality of commercially available antibodies and the dearth of antibodies for numerous targets.
(Sep 8, 2009)
|
